Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-08
2007-05-08
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S271000
Reexamination Certificate
active
10517788
ABSTRACT:
The invention provides a compound of formula (I) and pharmaceutically acceptable salts thereof. Processes for the isolating of this bafilomycin metabolite from a novelMicromonosporaspecies, pharmaceutical compositions containing this metabolite and methods of treatment using said metabolite are also described
REFERENCES:
patent: 4558139 (1985-12-01), Hagenmaier et al.
patent: 0689839 (1995-06-01), None
patent: 0 689 839 (1996-01-01), None
patent: WO 93/18652 (1993-09-01), None
patent: WO 01/02413 (2001-01-01), None
International Search Report dated Oct. 8, 2003 for related International Application No. PCT/EP03/50276.
Janicot Michel Marie François
Laakso Jodi Ann
Mocek Ursula Maria
Van Dun Jacobus Alphonsus Josephus
Wouters Walter Boudewijn Leopold
Donnelly Laura
Janssen Pharmaceutica N.V.
Rahmani Niloofar
Seaman D. Margaret
LandOfFree
Bafilomycin-like metabolite from a novel micromonospora... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bafilomycin-like metabolite from a novel micromonospora..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bafilomycin-like metabolite from a novel micromonospora... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3768951